For Healthcare Professionals: Lung Cancer

At Memorial Sloan Kettering we offer the latest innovations in lung cancer detection and therapy, including genetic testing of tumors and clinical trials of new therapies and drug combinations.

Our thoracic surgery team performs more lung cancer surgeries than any other medical center in the New York metropolitan area ─ more than 500 each year ─ ranking it among the highest-volume centers in the nation. Whenever possible, we use minimally invasive approaches, including robotic and video-assisted thoracic surgery (VATS), which are associated with faster recovery times than traditional open surgeries.

Refering a Patient

Call 866-218-8132
Mon–Fri, 8:30 AM–5:30 PM, ET

Find an Expert | See Clinical Trials | Request a Pathology Consult

Lung Cancer Screening Decision Tool

Major organizations and doctors at Memorial Sloan Kettering Cancer Center recommend you consider being screened only if you are at least 55 years old and have 30 pack years of smoking or more. But even if you meet these criteria, the chance you will get lung cancer is unique to you.

Pictured: Martee Hensley
Screening Guidelines

Memorial Sloan Kettering screening guidelines for select patients involves low-dose helical CT of the chest at specific intervals.

Pictured: Martee Hensley
Pictured: Manjit Bains
Lung Cancer Information for Your Patients

The Memorial Sloan Kettering approach to diagnosis and treatment of lung cancer in patient-friendly language

Pictured: Manjit Bains

E-Publications for Medical Professionals

Stay up-to-date on Memorial Sloan Kettering advances in your areas of interest.

Subscribe to OncoNotes »

Glomus Tumor at Tracheal Carina

Thoracic surgeon Robert Downey describes the diagnosis and treatment of a rare glomus tumor situated at the tracheal bifurcation in a male marathon runner.

Pictured: Paul Paik
Personalizing Treatment: Mutations Identified in Squamous Cell Lung Cancer Tumors

Medical oncologist Paul Paik discusses the Squamous Cell Carcinoma of the Lung Mutation Analysis Program (SQ-MAP) and various open clinical trials.

Tracheal Glomus
Pictured: Paul Paik
Squamous Cell Lung Mutations